Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Meheco Group CoSHSE:600056 -1.66%61 EV-to-FCF is 17.38 as of Jul. 21, 2026, which is 6% below its 10-year median of 18.45. GuruFocus rates SHSE:600056 with a GF Score™ of 61/100 and a GF Value™ of ¥10.47 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 72 Medical Distribution companies, China Meheco Group Co ranks better than 50% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, China Meheco Group Co's Enterprise Value is ¥19,963 Mil.
China Meheco Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥1,149 Mil. Therefore, China Meheco Group Co's EV-to-FCF for today is 17.38.
The historical rank and industry rank for China Meheco Group Co's EV-to-FCF or its related term are showing as below:
SHSE:600056'
s EV-to-FCF Range Over the Past 10 Years
Min: -585.77 Med: 18.45 Max: 150.29
Current: 17.09
During the past 13 years, the highest EV-to-FCF of China Meheco Group Co was 150.29. The lowest was -585.77. And the median was 18.45.
SHSE:600056's EV-to-FCF is ranked better than 50% of 72
companies
in the Medical Distribution industry
Industry Median: 17.28
vs SHSE:600056: 17.09
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Meheco Group Co (SHSE:600056) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Meheco Group Co's PE Ratio (TTM) for today is calculated as:
China Meheco Group Co's share price for today is ¥9.45.
China Meheco Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.323.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600056 vs MCK, CAH, COR: EV-to-FCF Comparison
For the Medical Distribution subindustry, China Meheco Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Meheco Group Co EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China Meheco Group Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where China Meheco Group Co's EV-to-FCF falls into.
China Meheco Group Co's current Enterprise Value is ¥19,963 Mil.
China Meheco Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,149 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Meheco Group Co (SHSE:600056) has a EV-to-FCF of 17.38 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Meheco Group Co and its competitors. This is near median its historical median of 18.45. According to the industry distribution chart, China Meheco Group Co ranks #36 out of 72 companies in the Medical Distribution industry, placing it in the top 50%.
Is China Meheco Group Co's EV-to-FCF too high?
China Meheco Group Co's current EV-to-FCF of 17.38 is near median its 10-year median of 18.45. The Medical Distribution industry median EV-to-FCF is 17.28. China Meheco Group Co's value of 17.38 is 0.6% above this industry median. Based on the distribution chart, China Meheco Group Co ranks #36 out of 72 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, China Meheco Group Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Meheco Group Co's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, China Meheco Group Co ranks #36 out of 72 companies for EV-to-FCF. This puts China Meheco Group Co in the upper half of its industry. The industry median EV-to-FCF is 17.28. China Meheco Group Co's value of 17.38 is 0.6% above this benchmark. While the company's 10-year median is 18.45 vs. the industry median of 17.28, China Meheco Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.28, based on 72 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Meheco Group Co's current EV-to-FCF of 17.38 is 0.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Meheco Group Co and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Meheco Group Co's current EV-to-FCF is 17.38, which is near median its own 10-year median of 18.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Meheco Group Co stock overvalued right now?
Based on GuruFocus' analysis, China Meheco Group Co (SHSE:600056) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.47, compared to a current price of ¥9.45 — trading 9.7% below its estimated fair value. The current EV-to-FCF is 17.38, which is near median its 10-year median of 18.45 and 0.6% above the Medical Distribution industry median of 17.28. China Meheco Group Co's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For China Meheco Group Co (SHSE:600056), the current EV-to-FCF is 17.38 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Meheco Group Co (SHSE:600056) Overvalued in 2026?
Based on GuruFocus' analysis, China Meheco Group Co stock appears to be undervalued.
The current stock price of ¥9.45 is trading 9.7% below its estimated GF Value™ of ¥10.47.
GuruFocus considers China Meheco Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:600056:
EV-to-FCF: 17.38 (near median its 10-year median of 18.45)
GF Value™: ¥10.47 vs. price of ¥9.45 (9.7% below fair value)
Industry Position: 0.6% above the Medical Distribution median (#36 of 72)
No single metric tells the full story. See the SHSE:600056 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, and Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, and logistics to international trading, academic promotion, and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products, and others.
61GF Score
Get the complete analysis for SHSE:600056
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600056 has been successfully added to your 
